Cover Image
市場調查報告書

甲一型抗胰蛋白酵素缺乏症(α1-抗胰蛋白酶缺乏症(AAT缺乏症)):全球臨床實驗趨勢

Alpha Antitrypsin Deficiency Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 339708
出版日期 內容資訊 英文 86 Pages
訂單完成後即時交付
價格
Back to Top
甲一型抗胰蛋白酵素缺乏症(α1-抗胰蛋白酶缺乏症(AAT缺乏症)):全球臨床實驗趨勢 Alpha Antitrypsin Deficiency Global Clinical Trials Review, H2, 2015
出版日期: 2015年08月19日 內容資訊: 英文 86 Pages
簡介

本報告提供甲一型抗胰蛋白酵素缺乏症臨床實驗相關之最新趨勢分析,提供您各地區的主要國家臨床實驗數量,臨床實驗的各階段進展,實驗對象採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,以及潛力藥劑比較等資訊。

簡介

  • 甲一型抗胰蛋白酵素缺乏症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:遺傳性疾病治療藥臨床實驗上甲一型抗胰蛋白酵素缺乏症的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:遺傳性疾病治療藥臨床實驗上甲一型抗胰蛋白酵素缺乏症的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

甲一型抗胰蛋白酵素缺乏症治療藥臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Baxter International Inc.
    • Kamada Ltd.
    • Grifols, S.A.
    • Grifols Therapeutics, Inc. (Inactive)
    • CSL Limited
    • Arriva Pharmaceuticals, Inc.
    • Applied Genetic Technologies Corporation
    • Bayer AG
    • Arrowhead Research Corporation
    • Alnylam Pharmaceuticals, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • University of Florida
    • University of Massachusetts
    • University of Miami
    • University of Pittsburgh
    • Weill Cornell Medical College

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2834CTIDB

GlobalData's clinical trial report, "Alpha Antitrypsin Deficiency Global Clinical Trials Review, H2, 2015" provides an overview of Alpha- Antitrypsin Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Alpha- Antitrypsin Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Alpha- Antitrypsin Deficiency
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Alpha- Antitrypsin Deficiency
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Alpha- Antitrypsin Deficiency
      • Jul 08, 2015: Arrowhead Receives Regulatory Clearance for ARC-AAT Phase 1 in the United Kingdom and New Zealand
      • Jul 02, 2015: Arrowhead Initiates Dosing of ARC-AAT in Patients with Alpha-1 Antitrypsin Deficiency
      • Jun 01, 2015: The Lancet Publishes CSL Behring's Alpha-1 Antitrypsin Deficiency Study Data
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Baxter International Inc.
      • Clinical Trial Overview of Baxter International Inc.
      • Kamada Ltd.
      • Clinical Trial Overview of Kamada Ltd.
      • Grifols, S.A.
      • Clinical Trial Overview of Grifols, S.A.
      • Grifols Therapeutics, Inc. (Inactive)
      • Clinical Trial Overview of Grifols Therapeutics, Inc. (Inactive)
      • CSL Limited
      • Clinical Trial Overview of CSL Limited
      • Arriva Pharmaceuticals, Inc.
      • Clinical Trial Overview of Arriva Pharmaceuticals, Inc.
      • Applied Genetic Technologies Corporation
      • Clinical Trial Overview of Applied Genetic Technologies Corporation
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Arrowhead Research Corporation
      • Clinical Trial Overview of Arrowhead Research Corporation
      • Alnylam Pharmaceuticals, Inc.
      • Clinical Trial Overview of Alnylam Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • University of Florida
      • Clinical Trial Overview of University of Florida
      • University of Massachusetts
      • Clinical Trial Overview of University of Massachusetts
      • University of Miami
      • Clinical Trial Overview of University of Miami
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • Weill Cornell Medical College
      • Clinical Trial Overview of Weill Cornell Medical College
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Region, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, G7 Countries (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, E7 Countries (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Kamada Ltd., 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols Therapeutics, Inc. (Inactive), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Arriva Pharmaceuticals, Inc., 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Applied Genetic Technologies Corporation, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Arrowhead Research Corporation, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Alnylam Pharmaceuticals, Inc., 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2015*

List of Figures

  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, G7 Countries (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, E7 Countries (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top